SOUFFLÉ THERAPEUTICS, INC. (“Soufflé™” or “Company”), a leading RNA therapies company aimed at advancing the next generation of therapies designed to help people live healthier lives, today announced ...
Oversubscribed financing led by Juvia Group, welcomes an expanded syndicate of leading institutional investors, reflecting strong conviction in Soufflé’s team, product engine and pipeline. Proceeds ...
SUZHOU, China, Oct. 2, 2026 /PRNewswire/ -- Abogen Biosciences ("Abogen" or the "Group"), a clinical-stage biotechnology group pioneering RNA innovation, announced that it has entered into a licensing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results